1. Discuss lung cancer at early stages is key to intervention strategies.
2. Discuss local immune microenvironment may contribute to precancer in lung squamous cell carcinoma.
3. Discuss how Imaging mass cytometry may provide a useful tool for understanding the immune microenvironment.
Tachira Pichardo, PhD, Presenter, received graft funding from the Johnson & Johnson Lung Cancer Initiative on Non-small cell lung cancer, squamous cell carcinoma, immunoprevention.
- 0.50 AMA PRA Category 1 Credit™Boston University School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. Boston University School of Medicine designates this Live activity for a maximum of 0.50 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
- 0.50 Participation